An extension cohort was included to obtain an insight into toxicities in a larger set of patients, and to obtain an insight in anti-tumour effects and pharmacodynamics in an exploratory analysis of VEGF and ET-1 kinetics. This evidence concerns the gene EDN1 and neoplasm.